Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-K/A
Source: 0001731122-25-000252
Chunk: 165

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-K/A
Chunk 165
---
     |                    |   642,128 |     |                                             | 4.96 |     |                                 |      |
|                                                        |       |     | $              | 1.48 |     |                    |    50,740 |     |                                             | 4.99 |     |                                 |      |     |                    |    50,740 |     |                                             | 4.99 |     |                                 |      |
|                                                        | Total |     |                |      |     |                    | 3,094,876 |     |                                             | 3.48 |     | $                               | 1.00 |     |                    | 3,094,876 |     |                                             | 3.48 |     | $                               | 1.00 |

A summary of the warrant activity is presented below:

| Schedule of warrants outstanding             |     | Shares |            |   |     | Weighted Average Exercise 
 Price                     |      |     | Weighted Average Remaining 
 Life                       |      |
|:---------------------------------------------|:----|:-------|-----------:|:--|:----|:--------------------------|-----:|:----|:---------------------------|-----:|
| Outstanding at June 30, 2023                 |     |        |  3,548,302 |   |     | $                         | 0.73 |     |                            | 4.80 |
| Granted                                      |     |        |  3,497,918 |   |     | $                         | 0.81 |     |                            | 4.27 |
| Exercised                                    |     |        | (3,951,344 | ) |     | $                         | 0.59 |     |                            |    — |
| Cancelled/Expired                            |     |        |          — |   |     | $                         |    — |     |                            |    — |
| Outstanding and exercisable at June 30, 2024 |     |        |  3,094,876 |   |     | $                         | 1.00 |     |                            | 3.48 |

At June 30, 2024, the Company had 3,094,876 exercisable Common Stock Purchase
Warrants outstanding. The total intrinsic value of warrants exercisable at June 30, 2024, was $2,309,681.
Intrinsic value is measured using the fair market value at the date of exercise (